Todd S Thomson insider trades: Actuate Therapeutics (ACTU) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Todd reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | ACTU | ↓ Sell | 280,000 | $5.80 | $1.6M | By Kairos Venture Partners II, L.P. | Jan 7, 2026 (2d) |
| Aug 14, 2024 | ACTU | ↓ Sell | 18,750 | $8.00 | $150K | By KVP II, L.P. | Aug 16, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACTU insiders
Open-market trades in the last 12 months
About Todd S Thomson's insider trades
Todd S Thomson is an insider at Actuate Therapeutics (ACTU). Since Aug 14, 2024, Todd has reported no open-market purchases and 2 sales worth $1.8M on SEC Form 4. In the last 12 months: 1 sale ($1.6M).
Their filings also include grants and awards (15 filings), shares withheld for taxes (6 filings), option exercises (5 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACTU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.